Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2018 Jun 15;17(9):1859–1870. doi: 10.1158/1535-7163.MCT-17-1176

Figure 2. In vitro effects of bromocriptine on PCa cells.

Figure 2

(A) MTS assay of the viability of C4-2 cells treated with varying concentrations of bromocriptine for 72 h. (B) Proliferation of C4-2 cells in response to varying concentrations of bromocriptine. Cell numbers were counted with an automated cell counter at different time points. * p < 0.05. (C) Flow cytometry assay of Annexin V expression in C4-2 cells treated with varying concentrations of bromocriptine (72 h). p < 0.05 in all pairwise comparisons (t-test). (D) Flow cytometry assay of the cell cycle of C4-2 cells treated with varying concentrations of bromocriptine (48 h). *, **, ***: p < 0.05 (t-test).